Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
University Health Network, Toronto
St. Olavs Hospital
University of California, San Diego
Columbia University
Shanghai Jiao Tong University School of Medicine
National Cancer Institute, Naples
Cantonal Hospital of St. Gallen
Ruhr University of Bochum
Ruhr University of Bochum
China Medical University Hospital
Royal Marsden NHS Foundation Trust
Yonsei University
The University of Hong Kong
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Rigshospitalet, Denmark
Japan Clinical Oncology Group
The First Affiliated Hospital with Nanjing Medical University
M.D. Anderson Cancer Center
UNICANCER
Seoul National University Hospital
Stanford University
Sun Yat-sen University
Assistance Publique - Hôpitaux de Paris
University of Arkansas
Shanghai Jiao Tong University School of Medicine
Gachon University Gil Medical Center